The C11orf30-LRRC32 region is associated with total serum IgE levels in asthmatic patients - 03/02/12
Doi : 10.1016/j.jaci.2011.09.040
Xingnan Li, PhD, MS a 
, Elizabeth J. Ampleford, PhD a, Timothy D. Howard, PhD a, Wendy C. Moore, MD a, Huashi Li, MS a, William W. Busse, MD b, Mario Castro, MD c, Serpil C. Erzurum, MD d, Anne M. Fitzpatrick, PhD e, Benjamin Gaston, MD f, Elliot Israel, MD g, Nizar N. Jarjour, MD h, W. Gerald Teague, MD f, Sally E. Wenzel, MD i, Gregory A. Hawkins, PhD a, Eugene R. Bleecker, MD a, Deborah A. Meyers, PhD a
, Elizabeth J. Ampleford, PhD a, Timothy D. Howard, PhD a, Wendy C. Moore, MD a, Huashi Li, MS a, William W. Busse, MD b, Mario Castro, MD c, Serpil C. Erzurum, MD d, Anne M. Fitzpatrick, PhD e, Benjamin Gaston, MD f, Elliot Israel, MD g, Nizar N. Jarjour, MD h, W. Gerald Teague, MD f, Sally E. Wenzel, MD i, Gregory A. Hawkins, PhD a, Eugene R. Bleecker, MD a, Deborah A. Meyers, PhD a a Center for Genomics and Personalized Medicine Research, Wake Forest University School of Medicine, Winston-Salem, NC
b Department of Medicine, University of Wisconsin, Madison, Wis
c Departments of Medicine and Pediatrics, Washington University School of Medicine, St Louis, Mo
d Lerner Research Institute, Cleveland, Ohio
e Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga
f Department of Pediatrics, University of Virginia Health Systems, Charlottesville, Va
g Brigham & Women’s Hospital, Harvard University, Boston, Mass
h Departments of Medicine and Public Health Sciences, University of Wisconsin Hospitals and Clinics, Madison, Wis
i Department of Medicine, University of Pittsburgh, Pittsburgh, Pa
| SARP centers were supported by National Institutes of Health (NIH) grants HL69116, HL69130, HL69149, HL69155, HL69167, HL69170, HL69174, HL69349, UL1RR024992, M01RR018390, M01RR07122, M01RR03186, HL087665, and HL091762. Genetic studies for SARP and CSGA were funded by NIH grant HL87665. The clinical TENOR study was supported by Genentech, Inc, and Novartis Pharmaceuticals Corporation, and the genetic studies were funded by NIH grants HL76285 and HL87665. |
|
| Disclosure of potential conflict of interest: W. W. Busse is on the advisory board for Centocor and Merck; is a consultant for Amgen, AstraZeneca, Novartis, GlaxoSmithKline, MedImmune, and Genentech; and has received research support from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) and the NIH/National Heart, Lung, and Blood Institute (NHLBI). M. Castro is a consultant and speaker for Asthmatx; is on the advisory board of and speaker for Genentech; is a speaker for AstraZeneca, Merck, and GlaxoSmithKline; has received grants through his institution from Asthmatx, Amgen, Ception/Cephalon, Genentech, MedImmune, Merck, Novartis, the NIH, and GlaxoSmithKline; has received royalties from Elsevier; and has received research support from the NIH. S. C. Erzurum has received research support from Asthmatx. B. Gaston is on the advisory board of Respiratory Research, Inc, and Galleon Pharmaceuticals and has received research support from the NIH. N. N. Jarjour has received research support from GlaxoSmithKline, Merck, and Genentech and has provided legal consultation services/expert witness testimony for Genentech and Asthmatx. G. A. Hawkins has received research support from the NIH. The rest of the authors declare that they no relevant conflicts of interest. |
© 2011
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 129 - N° 2
P. 575 - février 2012 Retour au numéro
Article précédent
- IL-1 receptor–associated kinase 3 gene (IRAK3) variants associate with asthma in a replication study in the Spanish population
- María Pino-Yanes, Inmaculada Sánchez-Machín, José Cumplido, Javier Figueroa, María José Torres-Galván, Ruperto González, Almudena Corrales, Orlando Acosta-Fernández, José Carlos García-Robaina, Teresa Carrillo, Anselmo Sánchez-Palacios, Jesús Villar, Mariano Hernández, Carlos Flores
- A rapid screening method to detect autosomal-dominant ectodermal dysplasia with immune deficiency syndrome
- Hidenori Ohnishi, Rie Miyata, Tomonori Suzuki, Touichiro Nose, Kazuo Kubota, Zenichiro Kato, Hideo Kaneko, Naomi Kondo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?